Dr. Michael R. Sperling

Gastroenterology
113 Gainsborough Sq Ste 202, 
Chesapeake, VA 
113 Gainsborough Sq Ste 202, 
Chesapeake, VA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Sperling is a Gastroenterologist in Chesapeake, Virginia. Dr. Sperling is rated as an Experienced provider by MediFind in the treatment of Fecal Impaction. His top areas of expertise are Hiatal Hernia, Congenital Diaphragmatic Hernia, Swallowing Difficulty, Deep Brain Stimulation, and Endoscopy.

His clinical research consists of co-authoring 419 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in VA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

113 Gainsborough Sq Ste 202, Chesapeake, VA 23320

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
Enrollment Status: Terminated
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
Stereotactic Laser Ablation for Temporal Lobe Epilepsy
Stereotactic Laser Ablation for Temporal Lobe Epilepsy
Enrollment Status: Completed
Publish Date: January 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
Memory Retrieval and Encoding Investigated by Neural Stimulation
Memory Retrieval and Encoding Investigated by Neural Stimulation
Enrollment Status: Active_not_recruiting
Publish Date: November 05, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drug: YKP3089
Study Phase: Phase 3
A Phase 2a, Safety, Tolerability, Pharmacokinetics, and Quantitative EEG Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures
A Phase 2a, Safety, Tolerability, Pharmacokinetics, and Quantitative EEG Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures
Enrollment Status: Completed
Publish Date: September 08, 2022
Intervention Type: Drug
Study Phase: Phase 2
A 12-Month Open-Label, Repeat-Dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)
A 12-Month Open-Label, Repeat-Dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)
Enrollment Status: Completed
Publish Date: January 31, 2022
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects Under Seizure and Normal Conditions
An Open-Label, Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects Under Seizure and Normal Conditions
Enrollment Status: Completed
Publish Date: October 05, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

419 Total Publications

Neural components underlying successful free recall are specific to episodic memory.
Neural components underlying successful free recall are specific to episodic memory.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2025
Similar Doctors
Experienced in Fecal Impaction
Dr. Douglas Howerton
Gastroenterology
Experienced in Fecal Impaction
Dr. Douglas Howerton
Gastroenterology

Capital Digestive Care LLC

113 Gainsborough Sq, Suite 101, 
Chesapeake, VA 
 (1.7 miles away)
757-436-3285
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Douglas Howerton is a Gastroenterologist in Chesapeake, Virginia. Dr. Howerton is rated as a Distinguished provider by MediFind in the treatment of Fecal Impaction. His top areas of expertise are Acute Pancreatitis, Childhood Pancreatitis, Choledocholithiasis, Endoscopy, and Pancreatectomy.

Experienced in Fecal Impaction
Dr. Alan Tieu
Gastroenterology
Experienced in Fecal Impaction
Dr. Alan Tieu
Gastroenterology

Capital Digestive Care LLC

885 Kempsville Rd, Suite 114, 
Norfolk, VA 
 (7.1 miles away)
757-466-0165
Languages Spoken:
English
See accepted insurances

Alan Tieu is a Gastroenterologist in Norfolk, Virginia. Dr. Tieu is rated as a Distinguished provider by MediFind in the treatment of Fecal Impaction. His top areas of expertise are Watermelon Stomach, Angiodysplasia of the Colon, Hemorrhoids, Endoscopy, and Gastrectomy.

Experienced in Fecal Impaction
Dr. Trent Martin
Gastroenterology
Experienced in Fecal Impaction
Dr. Trent Martin
Gastroenterology

Capital Digestive Care LLC

1925 Glenn Mitchell Dr, Suite 102, 
Virginia Beach, VA 
 (6.9 miles away)
757-464-1644
Languages Spoken:
English
See accepted insurances

Trent Martin is a Gastroenterologist in Virginia Beach, Virginia. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Fecal Impaction. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Gastric Dysmotility, Swallowing Difficulty, Colonoscopy, and Endoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sperling's expertise for a condition
ConditionClose
      View All 41 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile